Opinion|Videos|March 14, 2025
CGM's Impact on Clinical Inertia
This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss how continuous glucose monitoring (CGM) adoption impacts clinical inertia and supports earlier therapeutic interventions across different patient populations, highlighting measurable improvements in patient outcomes, such as glycemic control, hemoglobin A1c (HbA1c) levels, hypoglycemic events, and quality of life.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How does CGM adoption impact clinical inertia and support earlier therapeutic interventions across different patient populations?
- What measurable improvements have been seen with CGMs in patient outcomes (eg, glycemic control, HbA1c levels, hypoglycemic events, quality of life)?
- Because each segment is considered a separate entity, each group of discussion questions should reset with No. 1 if using numbers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose
3
5 Questions Dermatology Patients May Have About Newly-Approved Bemotrizinol
4
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
5